Keywords: roche, trimeris, complete, ph, iii, t-20, trial

Roche and Trimeris complete Ph III T-20 trial enrollment

Article | 10 August 2001

Print This

Roche and Trimeris have completed enrollment in their two pivotal PhaseIII clinical trials for the fusion inhibitor T-20 for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in